-
May 6, 2020 Lupin Launches ‘Jan Kovid’ Helpline for Mumbai Citizens
-
May 5, 2020 Notice of Q4 FY2020 Board Meeting
-
May 4, 2020 Lupin Announces Positive Topline Results from its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis
-
April 30, 2020 Lupin’s Pithampur Unit-1 facility receives EIR from U.S. FDA
-
April 29, 2020 Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/
2 mL -
April 15, 2020 Lupin’s Mandideep Unit II Facility Receives EIR from U.S. FDA
-
April 13, 2020 Lupin’s Nagpur Facility Receives EIR from U.S. FDA
-
April 11, 2020 Lupin Contributes INR 21 crores Towards COVID-19 Relief Efforts
-
April 6, 2020 LuaLupin launches Mycophenolic Acid Delayed-Release Tablets USP
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications